Caprice R. Bearden, the company’s former compliance officer, pleaded guilty in November to multiple criminal charges related to the sale of over-potent drugs. She later testified against her boss, who was convicted and awaits sentencing.
Indianapolis-based Eli Lilly and Co. was one of the first drug firms to begin sharing prices. Now, others are following suit.
Long a leader in diabetes and neuroscience drugs, Eli Lilly and Co. is pushing hard and spending record sums to turbocharge its oncology business, potentially a huge growth area.
Bristol-Myers Squibb Co. on Friday won a shareholder vote to approve its takeover of Celgene Corp., paving the way to close the largest pharmaceutical merger in history and create a cancer-drug giant.
Paul Elmer, former owner and CEO of Pharmakon Pharmaceuticals in Noblesville, was convicted in federal court of nine counts of adulterating drugs and one count of conspiracy. He was acquitted of an additional count of obstruction of justice.
Paul Elmer, who founded Pharmakon 16 years ago and shut it down three years ago, faces charges of adulterating compounded drugs, conspiracy and obstructing a U.S. FDA investigation.
As the online retailer has moved into new industries over the years, consumers have flocked to it and numerous traditional retailers have closed their doors, unable to compete.
The suit accuses the companies of raising insulin sticker prices by more than 150 percent over five years, forcing diabetics to forgo the drug, take less insulin than needed or use expired versions
For a startup that has raised an eye-popping $71 million in just three years, Outpost Medicine LLC likes to keep a low profile. The young company, which is developing drugs for urinary and gastrointestinal disorders, is headquartered in small, unmarked space at the Parkwood Crossing office complex on East 96th Street. It has issued only a […]
The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers.
Increasingly, top researchers are questioning whether drugs such as Lantus from Sanofi, Levemir and Novolog from Novo Nordisk A/S, and Humalog from Eli Lilly and Co. are really needed for many patients.
Sen. Ron Wyden, the ranking Democrat on the committee, singled out Humalog, an insulin made by Indianapolis-based Eli Lilly and Co, as a drug with unwarranted price hikes.
Lartruvo shouldn’t be started in new patients, and those patients already taking it should ask their doctors if they should continue, U.S. regulators said, following a key study that failed to show the medicine prolonged lives.
Congress legalized the production and sale of industrial hemp and hemp derivatives, including CBD. But FDA Commissioner Scott Gottlieb has restated his agency’s stance that CBD is a drug ingredient and therefore illegal to add to food or health products without his agency’s approval.
The dispute between the world’s largest retail chain and the prominent pharmacy-benefits manager could roil the business of filling prescriptions.
Eli Lilly and Co. won’t put the price of its prescription drugs in television ads, as the Trump administration has called for pharmaceutical companies to do, but will begin promoting a website where prices are available.
A New Jersey-based company that acquired Cook Group’s drug-delivery technology unit in late 2017 has plans for a major expansion.
New employees at Eli Lilly and Co. get a letter encouraging them to join one of the pharmaceutical firm’s affinity groups. There’s one for African Americans, one for Latino employees—and four for Asians.
Indiana State Police collected more than a ton of expired and unwanted prescription medications Oct. 27 as part of the national “Prescription Drug Take Back” initiative sponsored by the U.S. Drug Enforcement Administration.
The crisis has been years in the making, and the job of wrestling it to the ground has grown into a massive task. No one is yet predicting when the state will be able to declare victory.
